Diasorin S.p.A.

Diasorin S.p.A. is a global leader in the biotechnology sector, specializing in the development, production, and marketing of diagnostic tests tailored to a variety of fields. These include infectious diseases, molecular diagnostics, oncology, endocrinology, and bone metabolism, serving both human and veterinary health markets. Headquartered in Saluggia, Italy, the company plays a pivotal role in the healthcare industry by providing innovative solutions designed to improve diagnostic capabilities and patient outcomes. Its extensive portfolio of high-quality diagnostic assays and biological testing technologies enables healthcare providers to swiftly and accurately diagnose and manage diseases. Diasorin’s commitment to research and development ensures a steady pipeline of cutting-edge products, maintaining its competitive edge and meeting the evolving demands of the marketplace. Through its comprehensive distribution network, Diasorin serves laboratories and medical facilities worldwide, contributing significantly to global public health initiatives and disease management strategies by focusing on reliable, efficient, and user-friendly diagnostic solutions.